Sleep Duration Shapes Next-Day Blood Sugar Control in Teenagers
Each extra hour of sleep reduces glucose variability and extreme excursion risk in healthy adolescents, a real-world CGM study finds.
20 articles
Each extra hour of sleep reduces glucose variability and extreme excursion risk in healthy adolescents, a real-world CGM study finds.
Applied Cognition tests a wearable device that tracks glymphatic function overnight, comparing it to MRI, EEG, and blood biomarkers.
New research reveals what happens to blood pressure between apnea events, exposing cardiovascular dangers that standard monitoring misses.
New research reveals how sleep quality directly impacts glucose control, offering actionable insights for diabetes management.
Study reveals how gestational diabetes significantly impairs sleep quality and shifts circadian rhythms toward evening preference.
Stanford researchers find pioglitazone and liraglutide improve CNS insulin signaling, measured via neuron-derived vesicles in blood.
Transdermal alcohol monitors paired with machine learning can now detect drinking events with over 90% accuracy β a leap beyond flawed self-reports.
New research maps beat-by-beat BP spikes following each apnea episode, revealing cardiovascular stress invisible to standard sleep studies.
New research reveals how glucose availability directs brain cell proliferation via a metabolic-epigenetic axis, with implications for MS and brain repair.
A landmark review proposes a paradigm shift in neurocritical care, moving from static ICP thresholds to dynamic intracranial monitoring of autoregulation, glymphatics, and compliance.
MethylCog, a 29-CpG blood test, indexes general cognitive ability and improves mild cognitive impairment detection beyond age and sex alone.
New study combines smartphone sensors, brain scans, and daily check-ins to predict suicide risk in vulnerable patients.
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
AI framework Reti-Pioneer screens for seven systemic diseases from a retinal photo, outperforming standard lab tests in speed and accuracy.
New research tracks the surging use of GLP-1 receptor agonists among adults with obstructive sleep apnea, raising questions about real-world impact.
Multi-night home sleep tests rival lab polysomnography for uncomplicated OSA, cutting costs and improving patient experience.
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
European sleep researchers update critical guidelines for measuring brain wave patterns that reveal sleep stability and quality.
A large NHANES study finds that the Cardiometabolic Index β combining visceral fat and lipid markers β independently predicts OSA symptoms with 75% higher odds.
Digital tracking through smartphone usage patterns successfully monitored recovery from Kleine-Levin syndrome episodes.